Immunosuppression overcomes insulin- and vector-specific immune responses that limit efficacy of AAV2/8-mediated insulin gene therapy in NOD mice (2018)
Attributed to:
Enabling technologies
funded by
MRC
Abstract
No abstract provided
Bibliographic Information
Digital Object Identifier: http://dx.doi.org/10.17863/cam.35029
Publication URI: https://www.repository.cam.ac.uk/handle/1810/287715
Type: Journal Article/Review